We are pleased to announce that the first electronic version of our VOX BÜHLMANN is out now. To read the latest news regarding our unique product portfolio click here: VOX BÜHLMANN_DE VOX BÜHLMANN_FR
- info@buhlmannlabs.ch
- +41 61 487 12 12
Blog Archives
We are pleased to announce the new 9 BÜHLMANN CAST® Allergens that will reinforce our commitment in the allergy diagnosis. With this release we will strengthen our Hymenoptera venom portfolio with a new dedicated allergen for the European paper wasp, as well as we developed alpha-GAL, a highly standardized allergen to address the new recognized
IBDoc® has now been on the market for over 2 years and it is transforming the way IBD patients manage their disease. IBDoc® is used by over a thousand patients in more than 15 countries and we now support 20 languages with Hebrew as the latest addition. BÜHLMANN as the only calprotectin company has been able
Interview with Anita Grünauer and Predrag Nesic, City Hospital Triemli, Zurich Deutsch Français Italiano English INTERVIEW* MIT ANITA GRÜNAUER UND PREDRAG NESIC, Stadtspital Triemli, Zürich Frau Grünauer, Herr Nesic, das Klinische-Chemie Team im ILM hat sich vor einigen Monaten entschieden den BÜHLMANN fCAL® turbo Test auf dem Roche Cobas® c501 in Ihrem Labor zu adaptieren.
Social Links